Lobbying Filing Details
Total Spending
$50,000
Activities
3
Lobbyists
3
Gov't Entities
6
Filing Information
- Filing UUID:
b5cfede5-5b94-4ee0-b665-6c8eae4aefe1- Type:
- Q2 - 2nd Quarter - Report
- Period:
- 2026 - 2nd Quarter (Apr 1 - June 30)
- Date Posted:
- July 17, 2026 at 6:54 PM
- Income:
- $50,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Jay B. Stewart
Registrant
HANCE SCARBOROUGH
Law Firm
Washington, District of ColumbiaClient
ALLIANCE FOR PHARMACY COMPOUNDING
Non-profit association promoting the practice of pharmacy compounding
Texas, United States of AmericaLobbying Activities (3)
Activity 1
Budget/AppropriationsIssues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations
Lobbyists (3)
- MICHAEL TOMBERLIN
- THERESA REED
- MR. ROBERT DAVID PORE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 2
Health IssuesIssues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations
Lobbyists (3)
- MICHAEL TOMBERLIN
- THERESA REED
- MR. ROBERT DAVID PORE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 3
PharmacyIssues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations
Lobbyists (3)
- MICHAEL TOMBERLIN
- THERESA REED
- MR. ROBERT DAVID PORE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES